☆ 4.4 Editorial Material

The Early Diagnosis of Alzheimer's Disease: A Patient-Centred Conversation with the Care Team

NEUROLOGY AND THERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Neurosciences

The probabilistic model of Alzheimer disease: the amyloid hypothesis revised

Giovanni B. Frisoni et al.

Summary: The amyloid hypothesis has long been the leading model for the pathogenesis of Alzheimer's disease, but a probabilistic model is proposed as an alternative due to the increasing understanding of the complex biology of Alzheimer's disease. This new model suggests that genetic factors, environmental exposures, and lower-risk genes play significant roles in different types of Alzheimer's disease, leading to a better understanding of disease pathophysiology and potentially accelerating the development of prevention and treatment strategies.

NATURE REVIEWS NEUROSCIENCE (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases

Elizabeth C. Mormino et al.

Summary: In vivo measurements using (18)F-PI-2620 PET scans revealed significant differences in brain regions associated with Alzheimer's disease across different stages of the disease. This indicates the potential of (18)F-PI-2620 as a tool for visualizing tau aggregations in AD.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Article Geriatrics & Gerontology

Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

Kristian S. Frederiksen et al.

Summary: The survey revealed variability in clinical practices across European expert centers diagnosing patients with MCI, highlighting the need for better biomarker counseling and training to improve communication skills. Future initiatives should emphasize the importance of communicating preventive strategies and advance planning.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Molecular Imaging Approaches in Dementia

Victor L. Villemagne et al.

Summary: The increasing prevalence of dementia requires healthcare providers to diagnose the disease in its early stages. Molecular imaging techniques like PET/SPECT can show protein abnormalities decades before symptoms appear. Development of novel tracers is ongoing to further understand the molecular pathologic characteristics of dementia disorders.

RADIOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management

James E. Galvin et al.

Summary: Alzheimer's disease is a progressive neurodegenerative disease that poses complex challenges for patients and caregivers. Early and accurate diagnosis is crucial for optimizing outcomes, yet many patients in the early stages remain undiagnosed due to barriers in the diagnostic journey. International experts have collaborated to create a patient-centered diagnostic blueprint for individuals in the early stages of AD.

FRONTIERS IN NEUROLOGY (2021)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

N. J. Ashton et al.

Summary: The development of blood biomarkers for Alzheimer's disease has shown promise for dementia diagnosis and early detection. Plasma p-tau has demonstrated analytical and clinical validity, while A beta's maturity level remains partially achieved. Despite progress in phases 1 through 3, more data is needed on covariate effects on biomarker measurement.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework

E. E. Wolters et al.

Summary: The maturity of [F-18]flortaucipir PET in AD biomarkers has been assessed based on the AD Biomarker Roadmap, showing high affinity and excellent discriminative accuracy for AD. However, further research is needed to fully establish its early detection ability and clinical utility.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

A. Leuzy et al.

Summary: By utilizing the Biomarker Roadmap methodology, experts assessed the maturity levels of CSF AD biomarkers in 2019 and found significant advancements in a unified protocol for CSF handling, introduction of certified reference methods for A beta 42, and fully automated assays. While progress has been made in phases one through three, further work is needed in phases four and five to assess real world performance and impact/cost.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

添加到收藏夹

Review Behavioral Sciences

Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis

Yu Mimura et al.

Summary: TMS is a non-invasive neurophysiological tool that can investigate cortical excitability in the human brain, and different TMS paradigms can assess the functions of various neural circuits. Studies have shown significant differences in cortical excitability and neural function between patients with AD and MCI compared to healthy controls, indicating the need for further research to differentiate these conditions.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

添加到收藏夹

Review Nutrition & Dietetics

Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia

Ligia J. Dominguez et al.

Summary: A combination of factors contribute to cognitive decline, with age being the main independent risk factor. Prevention of cognitive decline and dementia emphasizes the crucial role of diet, physical activity, and lifestyle factors.

NUTRIENTS (2021)

添加到收藏夹

Review Chemistry, Medicinal

Tauvid (TM): The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease

Caitlin V. M. L. Jie et al.

Summary: Tauvid, approved by the FDA in 2020 for PET imaging in AD patients, is a significant advancement in the field of AD research. This review summarizes the production, quality control, clinical application, pharmacology, and limitations of Tauvid, while also providing an overview of second-generation tau PET tracers.

PHARMACEUTICALS (2021)

添加到收藏夹

Article Mathematical & Computational Biology

Early MCI-to-AD Conversion Prediction Using Future Value Forecasting of Multimodal Features

Sidra Minhas et al.

Summary: This study developed a technique using multimodal MRI markers to predict the future progression from MCI to AD in patients, achieving high classification accuracy rates.

COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE (2021)

添加到收藏夹

Review Cell Biology

Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis

Yi-Jun Ge et al.

Summary: The study systematically evaluated retinal imaging and electrophysiological markers in patients with Alzheimer's disease, mild cognitive impairment, and preclinical AD. It found that these retinal biomarkers hold great potential for the diagnosis, prognosis, and risk assessment of AD and MCI. Further development of these biomarkers, especially in diagnostic test accuracy and longitudinal studies, is warranted in the future.

AGEING RESEARCH REVIEWS (2021)

添加到收藏夹

Article Clinical Neurology

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

Bruno Dubois et al.

Summary: The use of biomarkers in the diagnosis of Alzheimer's disease has limitations and should be used cautiously in a clinical setting, restricted to individuals with specific phenotypes and positive biomarkers. Biomarker-positive cognitively unimpaired individuals should be considered at-risk for progression to Alzheimer's disease.

LANCET NEUROLOGY (2021)

添加到收藏夹

Review Clinical Neurology

Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021

A. P. Porsteinsson et al.

Summary: Alzheimer's disease is a progressive and irreversible neurodegenerative disease that affects cognition, function, and behavior. Early and accurate diagnosis is crucial for patients and caregivers to plan for the future and make lifestyle changes. However, detecting early-stage Alzheimer's disease in clinical practice can be challenging and is hindered by various barriers.

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2021)

添加到收藏夹

Article Clinical Neurology

Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know

Claire M. Erickson et al.

Summary: The debate over disclosing personal disease-related information to asymptomatic adults has been ongoing in medicine and research. Recent studies have focused on the safety, psychological, and behavioral effects of disclosing AD-related genetic and biomarker information to cognitively unimpaired older adults. The article outlines concerns and rationale for AD biomarker disclosure and aims to address key questions regarding disclosure of amyloid positron emission tomography scan results to asymptomatic adults in a research setting.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)

添加到收藏夹

Article Clinical Neurology

Comparing CSF amyloid-beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status

Eline A. J. Willemse et al.

Summary: In this study, two novel automated biomarker assays showed that p-tau/Aβ(1-42), Aβ(1-42)/Aβ(1-40), and t-tau/Aβ(1-42) ratios had similar optimal concordance with amyloid PET compared to Aβ(1-42) alone.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)

添加到收藏夹

Review Medicine, General & Internal

Screening for Cognitive Impairment in Older Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Carrie D. Patnode et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Clinical Neurology

Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment

Alessandra E. Thomann et al.

ALZHEIMERS RESEARCH & THERAPY (2020)

添加到收藏夹

Article Geriatrics & Gerontology

Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial

Anna Rosenberg et al.

BMC GERIATRICS (2020)

添加到收藏夹

Article Clinical Neurology

Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment

Joshua D. Grill et al.

JAMA NEUROLOGY (2020)

添加到收藏夹

Review Geriatrics & Gerontology

Contributions of Modifiable Risk Factors to Dementia Incidence: A Bayesian Network Analysis

Jing-hong Liang et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)

添加到收藏夹

Article Clinical Neurology

Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

Gael Chetelat et al.

LANCET NEUROLOGY (2020)

添加到收藏夹

Article Clinical Neurology

2020 Alzheimer's disease facts and figures

[Anonymous]

ALZHEIMERS & DEMENTIA (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia A Randomized Clinical Trial

Jeff D. Williamson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

添加到收藏夹

Article Medicine, General & Internal

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

Gil D. Rabinovici et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

添加到收藏夹

Review Clinical Neurology

Advantages and disadvantages of the use of the CSF Amyloid (A) 42/40 ratio in the diagnosis of Alzheimer's Disease

Oskar Hansson et al.

ALZHEIMERS RESEARCH & THERAPY (2019)

添加到收藏夹

Article Clinical Neurology

2019 Alzheimer's disease facts and figures

Joseph Gaugler et al.

ALZHEIMERS & DEMENTIA (2019)

添加到收藏夹

Review Health Care Sciences & Services

Digital biomarkers for Alzheimer's disease: the mobile/wearable devices opportunity

Lampros C. Kourtis et al.

NPJ DIGITAL MEDICINE (2019)

添加到收藏夹

Article Clinical Neurology

Reconsidering frameworks of Alzheimer's dementia when assessing psychosocial outcomes

Joseph E. Gaugler et al.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)

添加到收藏夹

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

添加到收藏夹

Review Neurosciences

Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future

Jeffrey Cummings et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

添加到收藏夹

Review Clinical Neurology

Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

Victor L. Villemagne et al.

NATURE REVIEWS NEUROLOGY (2018)

添加到收藏夹

Review Neurosciences

Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease

Fuyuki Kametani et al.

FRONTIERS IN NEUROSCIENCE (2018)

添加到收藏夹

Article Geriatrics & Gerontology

Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia

James E. Galvin

CURRENT GERIATRICS REPORTS (2018)

添加到收藏夹

Review Clinical Neurology

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

Giovanni B. Frisoni et al.

LANCET NEUROLOGY (2017)

添加到收藏夹

Review Clinical Neurology

On the path to 2025: understanding the Alzheimer's disease continuum

Paul S. Aisen et al.

ALZHEIMERS RESEARCH & THERAPY (2017)

添加到收藏夹

Article Clinical Neurology

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

Flora H. Duits et al.

ALZHEIMERS & DEMENTIA (2016)

添加到收藏夹

Review Medicine, Research & Experimental

The amyloid hypothesis of Alzheimer's disease at 25years

Dennis J. Selkoe et al.

EMBO MOLECULAR MEDICINE (2016)

添加到收藏夹

Article Clinical Neurology

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

Frank Jessen et al.

ALZHEIMERS & DEMENTIA (2014)

添加到收藏夹

Article Geriatrics & Gerontology

Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease

Parunyou Julayanont et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)

添加到收藏夹

Article Clinical Neurology

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

Sylvain Lehmann et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

添加到收藏夹

Article Clinical Neurology

Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores

Monique M. Williams et al.

ALZHEIMERS & DEMENTIA (2013)

添加到收藏夹

Review Clinical Neurology

Assessment scales in dementia

Bart Sheehan

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors

Yue Cui et al.

PLOS ONE (2011)

添加到收藏夹

Article Medicine, Research & Experimental

Neuropathological Alterations in Alzheimer Disease

Alberto Serrano-Pozo et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)

添加到收藏夹

Review Behavioral Sciences

Cognitive reserve

Yaakov Stern

NEUROPSYCHOLOGIA (2009)

添加到收藏夹

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

添加到收藏夹

Article Clinical Neurology

Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function

DA Bennett et al.

ARCHIVES OF NEUROLOGY (2004)

添加到收藏夹

Review Clinical Neurology

Psychological impact of genetic testing for Huntington's disease: an update of the literature

B Meiser et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.